Back to Search
GLENN BEASLEY, M.D.
M.D.
Sports Medicine (Family Medicine) Physician
NPI: 1023141025Individual
Specialties, Licenses & Credentials
Family Medicine — Sports Medicine
Code: 207QS0010X
MD0000020673(TN)
Research & Publications (8)
A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma.
PMID 19637344·Cancer·2009
3-trial
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis.
PMID 19543771·Ann Surg Oncol·2009
4-observational
A multi-institutional experience of isolated limb infusion: defining response and toxicity in the US.
PMID 19476821·J Am Coll Surg·2009
4-observational
Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?
PMID 19184236·Ann Surg Oncol·2009
8-other
Current clinical and research approaches to optimizing regional chemotherapy: novel strategies generated through a better understanding of drug pharmacokinetics, drug resistance, and the development of clinically relevant animal models.
PMID 18722915·Surg Oncol Clin N Am·2008
6-review
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion.
PMID 18528730·Ann Surg Oncol·2008
3-trial
Future directions in regional treatment strategies for melanoma and sarcoma.
PMID 18393007·Int J Hyperthermia·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2158 NORTHGATE PARK LN, SUITE 104
CHATTANOOGA, TN 37415 - Phone
- (423) 870-2030
Quick Facts
- NPI
- 1023141025
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile